Skip to main content
Tech.eu· Cate Lawrence·· 7 days agoAI Score45

Efferon raises €4.3M to expand sepsis hemoadsorption technology into new markets

Efferon raises €4.3M to expand sepsis treatment technology into new markets

AI Overview

Efferon has raised €4.3 million from existing private investors in the DACH region to expand its hemoadsorption devices beyond critical care into healthy aging applications. The funding will support commercial expansion of Efferon LPS and Efferon NEO in Europe, India, and Latin America, plus its 21-distributor network and regulatory work. Efferon devices are used in 46 countries with over 30,000 treatments performed, and the company reported revenue above €1.1 million in 2025.

Source:Tech.eu · tech.eu

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing